Antibody Detection + Antibody Testing of Serious Fungal Infections
MiraVista Diagnostics specializes in antibody detection and antibody testing for serious fungal infections. Since 2002, we have been developing and processing diagnostic mycology tests that consistently produce results to the highest standards in clinical accuracy and sensitivity.
Antibody Detection Test Results You Can Trust
MiraVista Diagnostics currently offers immunodiffusion and EIA antibody detection tests for aspergillus, histoplasma, blastomyces and coccidioides. Download a test menu or contact us to learn more about our antibody detection tests.
NEW: MVista® Histoplasma Antibody IgG IgM EIA
Improve Diagnosis of Acute Pulmonary Histoplasmosis by Combining Antigen & Antibody Testing Review the technical specifications for the NEW MVista® Histoplasma Antibody IgG IgM EIA>> CLINICAL BACKGROUND Acute pulmonary histoplasmosis (APH) can be severe, especially following heavy exposure and is…
READ MORE →
BULLETIN: CSTE Revised Its Histoplasmosis Position Statement at the 2016 Annual Conference
The Council of State and Territorial Epidemiologists (CSTE) approved the Infectious Disease Committee’s revisions to the histoplasmosis position statement, “Standardized Surveillance Case Definition for Histoplasmosis” at the organization’s annual conference in Anchorage, Alaska on June 19-23, 2016. Review the revised…
READ MORE →
FEATURE: Diagnosing Histoplasmosis by Antigen Detection
FEATURED CASE REPORT FROM THE DESK OF: Lawrence Joseph Wheat, MD Medical Director, Founder & President of MiraVista Diagnostics Here is an important patient case report I’d like to share with colleagues about diagnosing histoplasmosis by antigen detection. I welcome…
READ MORE →
NEW: MVista® Coccidioides Antibody IgG IgM EIA
Improve Coccidioidomycosis Diagnosis with a New, More Sensitive, Anti-Coccidioides Antibody Enzyme Immunoassay CLINICAL BACKGROUND Coccidioidomycosis is endemic to the southwestern United States, northern Mexico and regions of Central and South America. Coccidioidomycosis often presents as community acquired pneumonia (CAP) and…
READ MORE →
MiraVista Diagnostics is Adding Jobs in Indianapolis to Meet Growing Market Demand
MiraVista Diagnostics is adding several new positions across all departments to meet growing market demand for its mycology diagnostic testing services. The scientific company is actively recruiting qualified candidates for research, medical laboratory, sales and technology positions in Indianapolis. Please…
READ MORE →
Dr. Joseph Wheat is Selected as the 2015 MMSA Billy Cooper Award Winner for His Contributions in Clinical Mycology
The Medical Mycological Society of the Americas selected MiraVista Diagnostics’ President, Founder and Medical Director, Lawrence Joseph Wheat, MD, as the 2015 MMSA Billy Cooper Award winner. This prestigious award is given to individuals with continuous outstanding or meritorious contributions in the…
READ MORE →
